Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
March 07 2024 - 4:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2024
Commission File Number 001-37381
MEDIGUS LTD.
(Translation of registrant’s name into English)
10 HaNechoshet Street Tel-Aviv, 6971072, Israel
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
EXPLANATORY NOTE
Medigus Ltd. (the “Company”),
hereby announces that the shareholders of the Company approved the proposal brought before the special general meeting of shareholders
scheduled for March 6, 2024 (the “Meeting”),
as originally proposed and included in the Company’s proxy statement for the Meeting, that was attached as Exhibit 99.1 to
a Report of Foreign Private Issuer on Form 6-K that the Company furnished to the Securities and Exchange Commission on February 12, 2024.
5,165,310 ordinary shares,
representing approximately 18.17% of the Company’s issued and outstanding ordinary shares as of the record date, were present or
represented by proxy at the Meeting.
This Form 6-K is incorporated
by reference into the Company’s Registration Statements on Form S-8 (File Nos. 333-258624, 333-206803, 333-221019, 333-229429
and 333-274190).
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
MEDIGUS LTD. |
|
|
|
Date: March 7, 2024 |
By: |
/s/ Tali Dinar |
|
|
Tali Dinar |
|
|
Chief Financial Officer |
2
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Oct 2023 to Oct 2024